scholarly article | Q13442814 |
P356 | DOI | 10.1158/1535-7163.MCT-12-0066 |
P698 | PubMed publication ID | 22389469 |
P50 | author | Liang-Hu Qu | Q30524430 |
Hui Zhou | Q55446111 | ||
P2093 | author name string | Hui-Lin Huang | |
Pan-Pan Zhao | |||
Chun-Hong Yu | |||
Qiao-Juan Huang | |||
Jun-Zhi Wen | |||
Lu-Qin Wang | |||
Heng-You Weng | |||
P2860 | cites work | Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells | Q40183990 |
P433 | issue | 5 | |
P921 | main subject | cell growth | Q189159 |
P304 | page(s) | 1155-1165 | |
P577 | publication date | 2012-03-02 | |
P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
P1476 | title | Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis | |
P478 | volume | 11 |
Q93197932 | A patent review of the ubiquitin ligase system: 2015-2018 |
Q28387804 | Discovery and development of natural product oridonin-inspired anticancer agents |
Q47636038 | E3 ubiquitin ligases in cancer and implications for therapies |
Q41922848 | Enterovirus 71 protease 2Apro and 3Cpro differentially inhibit the cellular endoplasmic reticulum-associated degradation (ERAD) pathway via distinct mechanisms, and enterovirus 71 hijacks ERAD component p97 to promote its replication. |
Q90746433 | F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects |
Q64244621 | FBXW7 in Cancer: What Has Been Unraveled Thus Far? |
Q39172323 | Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways. |
Q92675538 | Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment |
Q48151505 | Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth. |
Q26796359 | Molecular Insight in the Multifunctional Effects of Oridonin |
Q37609692 | Oridonin Triggers Chaperon-mediated Proteasomal Degradation of BCR-ABL in Leukemia. |
Q47156082 | Oridonin enhances in vitro anticancer effects of lentinan in SMMC-7721 human hepatoma cells through apoptotic genes |
Q49966626 | Oridonin increases anticancer effects of lentinan in HepG2 human hepatoblastoma cells |
Q37745233 | Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells |
Q34308761 | Oridonin: targeting programmed cell death pathways as an anti-tumour agent |
Q36259132 | Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. |
Q36600976 | Small molecule therapeutics targeting F-box proteins in cancer |
Q36303678 | Strategies to Inhibit Myc and Their Clinical Applicability |
Q38790535 | Suppression of c-Myc induces apoptosis via an AMPK/mTOR-dependent pathway by 4-O-methyl-ascochlorin in leukemia cells. |
Q37745377 | Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs |
Q47337952 | Targeting oncoproteins for degradation by small molecules in myeloid leukemia. |
Q57106057 | Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer |
Q26866185 | Targeting the ubiquitin pathway for cancer treatment |
Q90093670 | The role of ubiquitination in tumorigenesis and targeted drug discovery |
Q36552839 | Translational repression of cyclin D3 by a stable G-quadruplex in its 5' UTR: implications for cell cycle regulation |
Q36025441 | Tumor suppressor functions of FBW7 in cancer development and progression |
Q90133523 | Xanthohumol, a Prenylated Flavonoid from Hops, Induces Caspase-Dependent Degradation of Oncoprotein BCR-ABL in K562 Cells |
Q34315800 | ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids |
Q58699670 | miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways |
Search more.